NAT2 and tuberculosis: This study aimed to characterize clinically relevant polymorphisms in <i>NAT2</i>, <i>CYP2E1</i>, and <i>SLCO1B1</i> in a cohort of TB patients from Southern Peru, a genetically underrepresented Andean population.